Low-molecular weight heparins after orthopedic and trauma surgery in geriatric patients;Niedermolekulare heparine nach orthopädischen und traumatologischen operationen in der geriatrie

Zeitschrift fur Gerontologie und Geriatrie

Volumn 35, Issue 1, 2002, Pages 54-59

  Merkel, D ^a   Zippel, C ^a   Rech, P ^a  

^a Zentrum Berlin   (Germany)

Author keywords

Geriatrics; LMWH; Low molecular weight heparin; Prophylaxis; Thrombosis

Indexed keywords

CERTOPARIN; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN;

AGED; ARTICLE; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GERIATRIC PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; THROMBOEMBOLISM; TRAUMATOLOGY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CLINICAL TRIALS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS; WOUNDS AND INJURIES;

EID: 0036184504     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003910200008     Document Type: Article

References (41)

1. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement
2. Low-molecular-weight heparin (Enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
3. Wie lange sollte bei hochrisikopatienten eine postoperative thromboseprophylaxe durchgeführt werden?
4. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomised placebo-controlled study with dalteparin (Fragmin)
5. Low-molecular-weight heparin (Enoxaparin) vs dextran 70 in the prevention of postoperative deep vein thrombosis after total hip replacement
6. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery
7. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers
8. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement
9. Prevention of deep-vein thrombosis after total hip arthroplasty
10. A short course of low-molecular-weight heparin to prevent deep venous thrombosis after elective total hip replacement
11. Prävention, diagnostik und therapie von thrombosen in der orthopädie und unfallchirurgie
12. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine
13. Thromboembolic prophylaxis in orthopaedic trauma patients: A comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin
14. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement?
15. From unfractionated heparins to low molecular weight heparins
16. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement
17. Comparison of subcutaneous low-molecular-weight heparin with Warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation
18. Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement
19. Deep vein thrombosis in elderly Hong Kong Chinese with hip fractures detected with compression ultrasound and Doppler imaging: Incidence and effect of low molecular weight heparin
20. Use of low molecular weight heparin in preventing thromboembolism in trauma patients
21. Heparin/dihydroergotamine for venous thrombosis prohylaxis: Comparison of low-dose heparin and low molecular weight heparin in hip surgery
22. Incidence and prevention of deep venous thrombosis occurring late after general surgery: Randomised controlled study of prolonged thromboprophylaxis
23. Prevention of deep vein thrombosis after hip replacement: Randomised comparison between unfractionated heparin and low molecular weight heparin
24. Comparison of the thrombo-prophylactic effect of a low molecular weight heparin versus dextran in total hip replacement
25. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin r three times daily to prevent pulmonary embolism an venous thrombosis in patients with hip fracture
26. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: Enoxaparin
27. Prevention of deep vein thrombosis in knee arthroplasty
28. Prevention of deep vein thrombosis in patients with hip fractures: Low molecular weight heparin versus dextran
29. Leitlinien zur Thromboembolie-Prophylaxe
30. The effect of Enoxaparin in prevention of deep venous thrombosis in hip and knee surgery - A comparison with the dihydroergotamine-heparin combination
31. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures
32. The post-hospital discharge venous thrombosis risk of the orthopedic patient
33. Comparison of two low-molecular-weight heparins for the prevention of post-operative venous thromboembolism after elective hip surgery
34. Vergleich zwischen niedermolekularen und unfraktionierten heparinen in der thromboseprophpylaxe bei patienten mit totalendoprothetischem ersatz von hüft- und kniegelenk
35. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty
36. Thromboembolieprophylaxe mit niedermolekularem heparin in der orthopädischen
37. Evidence based medicine: What it is and what it isn't
38. Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery
39. Randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery
40. A prospective randomized study on the use of nadroparin calcium in the prophylaxis of thromboembolism in Korean patients undergoing elective total hip replacement